Value creation in the pharmaceutical industry : the critical path to innovation
| Other Authors: | , , |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
Weinheim, Germany :
Wiley-VCH
c2016
|
| Subjects: |
Table of Contents:
- 1. Introduction to the book
- 2. Global epidemiological developments
- 3. The value of pharmaceutical innovation: concepts and assessment
- 4. A review of the pharmaceuticalr&d efficiency: costs, timelines, and probabilities
- 5. Financing pharmaceutical innovation
- 6. Challenges and options for drug discovery
- 7. Translational medicine: enabling the proof of concepts
- 8. Preclinical safety and risk assessment
- 9. Developing commercial solutions for therapeutic proteins
- 10. The evolution of clinical development: from technical success to clinical value creation
- 11. Translational development
- 12. Forty years of innovation in biopharmaceuticals : will the next 40 years be as revolutionary?
- 13. Vaccines: where inertia, innovation, and revolution create value, simultaneously and quietly
- 14. The patient-centric pharma company: evolution, reboot, or revolution?
- 15. The pharmaceutical industry is opening its r&d boundaries